XML 19 R48.htm IDEA: XBRL DOCUMENT v2.3.0.15
AMIRA PHARMACEUTICALS, INC. ACQUISITION (Details) (Amira Pharmaceuticals [Member], USD $)
In Millions, unless otherwise specified
Sep. 30, 2011
Amira Pharmaceuticals [Member]
 
Acquisition [Line Items] 
Percentage of outstanding shares acquired100.00%
Purchase price paid in cash$ 325
Fair value of contingent consideration58
Aggregate purchase price383
Number of contingent milestone payments3
Contingent milestone payment amount50
Purchase price allocation - Cash15
Purchase price allocation - In-process research and development160
Purchase price allocation - Accrued expenses(16)
Purchase price allocation - Deferred tax liabilities(43)
Purchase price allocation - Total identifiable net assets116
Purchase price allocation - Goodwill267
In-process research and development valuation discount rate12.50%
Acquisition costs$ 1